An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence

Sébastien Antoni; Isabelle Soerjomataram; Bjørn Møller; Freddie Ian Bray; Jacques Ferlay

doi:10.2471/blt.15.164384

Abstract

1 min read

Although the performance of the GLOBOCAN methods varies by cancer site and sex in this study, the results emphasize a need for more high-quality population-based cancer registries - either regional or, where practical and feasible, national registries - to describe cancer patterns and trends for planning cancer control priorities.

Related publications

Article2001

Estimating the world cancer burden: Globocan 2000

D. Maxwell Parkin, Freddie Ian Bray, Jacques Ferlay, Paola Pisani

Article2024

The <scp>GLOBOCAN</scp> 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide

Adalberto Miranda‐Filho, Mathieu Laversanne, Jacques Ferlay, Murielle Colombet, Marion Piñeros, Ariana Znaor, Donald Maxwell Parkin, Isabelle Soerjomataram, Freddie Ian Bray

Chapter in a book2019

Cancer Registries

Sabine Siesling, Freddie Ian Bray, Roberto Zanetti, Tomohiro Matsuda, Anna Gavin, Adri C. Voogd, Betsy Kohler, Ryan McCabe

Article2018

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram, Colin Mathers, Donald Maxwell Parkin, Marion Piñeros, Ariana Znaor, Freddie Ian Bray

Article2014

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Souto Rebelo, Donald Maxwell Parkin, David Forman, Freddie Ian Bray